m
Recent Posts
Connect with:
Tuesday / March 5.
HomeminewsRayner Launches RayOne EMV Toric in Australia

Rayner Launches RayOne EMV Toric in Australia

RayOne EMV toric lens

The RayOne EMV Toric is now available in Australia.

Launched by Rayner, the new intraocular lens (IOL) is a variant of the ophthalmic manufacturer’s popular RayOne EMV that was developed in collaboration with world-renowned Australian surgeon, Professor Graham Barrett.

The RayOne EMV platform features a non-diffractive optic that provides patients with up to 1.5D1,2,3 of high-quality vision when used with an emmetropic target.

Excellent Surgeon Feedback

Rayner designed the toric variant in response to excellent surgeon feedback on RayOne EMV’s monofocal levels of contrast sensitivity1, dysphotopsia,4,5 and high levels of patient satisfaction.6

The company states that with the addition of this new IOL, surgeons can now correct from 0.5D of corneal astigmatism with a wide selection of IOL plane cylinders.

Queensland’s first commercial implanter of the RayOne EMV Toric IOL was Dr Graham Hay-Smith from Moreton Eye Group in Brisbane, who was “impressed with the excellent patient outcomes I have had with RayOne EMV backed up with audit data”.

These fantastic patient outcomes, coupled with my long-term confidence in rotational stability with the RayOne toric platform, made it an easy decision to implant the RayOne EMV Toric

A summarised audit of his initial RayOne EMV patient results demonstrated:

  • Excellent distance vision with no measurable compromise versus a standard monofocal,
  • Useful near/intermediate vision for most patients with emmetropic targeting,
  • The mini myopic group (mean target -0.49 D) maintains good UDVA: 0.1 LogMAR or better in 89% of patients),
  • The mini-monovision group (0.75 D myopia) displays an excellent range of vision: uncorrected distance visual acuity (UDVA) 0 LogMAR/better than N6 reading,
  • The modest-monovision group (i.e., 1.0 to 1.5 D of myopia) maintains uncorrected distance visual acuity, and can give even better (and closer) near vision.

Dr Hay-Smith said he finds the EMV a “very forgiving lens which appears to provide excellent physiological vision with a significant improvement in intermediate and near vision, compared to standard IOLs”.

Additionally, he noted patients were happy with the lens and that he has been surprised by how much intermediate and near functional vision he is observing.

A comparison of Dr Hay-Smith’s mini-monovision patients with uncorrected near vision acuity (UNVA) in each eye versus binocular UNVA using RayOne EMV Toric.

Figure 1. A comparison of Dr Hay-Smith’s mini-monovision patients with uncorrected near vision acuity (UNVA) in each eye versus binocular UNVA.

‘’These fantastic patient outcomes, coupled with my long-term confidence in rotational stability with the RayOne toric platform, made it an easy decision to implant the RayOne EMV Toric.

“I look forward to being able to provide the increased range and excellent quality of vision I’ve achieved with RayOne EMV to my astigmatic patients,’’ said Dr Hay-Smith.

RayOne EMV Toric is available to order in Australia and has Prosthesis List Reimbursement from 1 March 2023.

Contact: Rayner Australia (AUS) 1300RAYNER.

References
1. Ferreira TB. Comparison of visual outcomes of a monofocal, two enhanced monofocals and two extended depth of focus intraocular lenses. Presented at ESCRS 2022.
2. Rayner, data on file.
3. Royo, M. RayOne EMV and TECNIS Eyhance: A Comparative Clinical Defocus Curve. Data on file. 2021.
4. RayOne EMV: First Clinical Results, Rayner. Oct 2020.
5. Rayner RayPRO, data on file.
6. Rayner Peer2Peer webinar. May 2022.